Meeting
2017 Gastrointestinal Cancers Symposium
Immunoscore based on PD-L1/PD-1 and CD8+ T cells as prognostic marker for stage II/III gastric cancer.
Authors
Ti Wen
Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
Ti Wen , Xiujuan Qu , Yi Li , Zhi Li , Xiaofang Che , Yibo Fan , Shuo Wang , Ling Xu , Na Song , Yunpeng Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 69)
DOI
10.1200/JCO.2017.35.4_suppl.69
Abstract #
69
Poster Bd #
G3
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Prognostic impact of PD-1, PD-L1, and CD8 genes expression in peripheral blood in gastric cancer.
First Author: Shuhei Ito
Poster
2021 ASCO Annual Meeting
Examination of the tumor immune microenvironment (TIME) with multispectral immunofluorescence (m-IF): Association of markers with prognosis and bevacizumab (bev) benefit in NRG Oncology/NSABP C-08.
First Author: Katherine L. Pogue-Geile
Poster
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
First Author: Nicole Grace Chau
Poster
2022 ASCO Gastrointestinal Cancers Symposium
The immune impact of PI3K-AKT pathway inhibition in colorectal cancer.
First Author: Maliha Nusrat